There’s considerable buzz around the idea of letting trial participants use their own electronic devices to run trial apps, and the strategy has risen in popularity alongside the decentralized trials (DCT) movement. For sites unfamiliar with BYOD (bring your own device) trials, planning and prepping with the technology in mind is essential to managing this still evolving model successfully. Read More

The clinical trial payment process has long been frustrating for sites as well as sponsors and their CROs, with uncertain invoicing procedures, misunderstandings around payment terms and data entry complications often leading to late, incorrect or missed payments. Add to the picture the trend toward increased trial complexity, adoption of new technologies and the use of decentralized trial (DCT) methods, and all parties are feeling the pinch of payment problems more than ever. Read More

While the pandemic’s impact on clinical trials has been evident — trials paused or closed, new trial starts delayed, enrollment and retention declining — some hard data from two renowned research institutions have cast light on the pandemic experience. Read More

There’s been considerable skepticism about using decentralized trial (DCT) approaches in cancer trials, with procedural complexity, nature of disease and other considerations lending themselves more to in-person visits. But a new survey shows cancer patients have greater interest in trials when remote technology cuts down on travel and other participation burdens. Read More